AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Robert Rieveley, president of Biotech Holdings (BIO.V; BIOHF) announced that the company has completed the first production order of its Sucanon diabetes drug.
"I am pleased to report that our first production order is now completed. We have manufactured Sucanon for 1.2 million tablets or 20,000 1-month treatment packages. We project shipping this production to Mexico this week," Rieveley said.
"The sales value to Biotech of this shipment is in the range of $240,000 U.S.," Rieveley said.
"Monthly shipments of this volume, providing monthly treatment for 20,000 diabetics, would move us easily into profitability. With 10 million reporting Type II diabetics in Mexico and 10 million unreporting, we believe that Mexico offers tremendous potential for ongoing use of Sucanon as an effective and very safe treatment of type II diabetes symptoms. Our plant capacity of up to 400,000 1-month treatment packages can be readily expanded as needed," ...